Referencias
1. Bovaira M, García C, Calvo A, Desé J, Tortosa G, Bayarri V, et al. Actualizaciones en el abordaje terapéutico en el síndrome de dolor regional complejo. Rev Soc Esp Dolor. 2022;29(1):34-50. DOI: 1020986/resed20223978/2022.
2. Cohen SP, Bhatia A, Buvanendran A, Schwenk ES, Wasan AD, Hurley RW, et al. Consensus guidelines on the use of intravenous ketamine infusions for chronic pain from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists. Reg Anesth Pain Med. 2018;43(5):521-46.
3. Kirkpatrick AF, Saghafi A, Yang K, Qiu P, Alexander J, Bavry E, et al. Optimizing the Treatment of CRPS With Ketamine. Clin J Pain. 2020;36(7):516-23.
4. Chitneni A, Patil A, Dalal S, Ghorayeb JH, Pham YN, Grigoropoulos G. Use of Ketamine Infusions for Treatment of Complex Regional Pain Syndrome: A Systematic Review. Cureus. 2021;13(10):e18910.
5. Veraart JKE, Smith-Apeldoorn SY, Bakker IM, Visser BAE, Kamphuis J, Schoevers RA, et al. Pharmacodynamic Interactions Between Ketamine and Psychiatric Medications Used in the Treatment of Depression: A Systematic Review. Int J Neuropsychopharmacol. 2021;24(10):808-31.
6. Kutscher E, Greene RE. Ketamine Cystitis: An Underrecognized Cause of Dysuria. J Gen Intern Med. 2022;37(5):1286-9.
7. Cotter S, Wong J, Gada N, Gill R, Jones SC, Chai G, et al. Repeated or Continuous Medically Supervised Ketamine Administration Associated with Hepatobiliary Adverse Events: A Retrospective Case Series. Drug Saf. 2021;44(12):1365-74.
8. Mangnus TJP, Bharwani KD, Stronks DL, Dirckx M, Huygen FJPM. Ketamine therapy for chronic pain in The Netherlands: a nationwide survey. Scand J Pain. 2021;22(1):97-105.